Kiniksa Pharmaceuticals International, Plc
Clinical trials sponsored by Kiniksa Pharmaceuticals International, Plc, explained in plain language.
-
New drug switch aims to simplify treatment for recurring heart inflammation
Disease control Recruiting nowThis study tests how well people with well-controlled recurrent pericarditis (a condition where the heart's lining swells repeatedly) can switch from their current treatments to a new drug called KPL-387 taken alone. About 80 adults will be enrolled to find the best dosing plan a…
Phase: PHASE2 • Sponsor: Kiniksa Pharmaceuticals International, plc • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New hope for heart inflammation sufferers: KPL-387 trial launches
Disease control Recruiting nowThis study tests whether a new drug called KPL-387 can safely and effectively treat recurrent pericarditis, a condition where the lining around the heart becomes inflamed again and again. About 165 adults who still have symptoms despite standard treatments will take part. The goa…
Phase: PHASE2, PHASE3 • Sponsor: Kiniksa Pharmaceuticals International, plc • Aim: Disease control
Last updated May 15, 2026 11:55 UTC